Vanguard Group Inc. has significantly bolstered its investment in Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage oncology company known for its development of antibody drug conjugates (ADCs). According to the most recent 13F filing with the Securities and Exchange Commission (SEC), Vanguard
In the rapidly evolving field of biopharmaceuticals, the quest for high-quality biologics hinges on the ability to thoroughly analyze and understand complex protein structures. The critical role of proteomics—a branch of biochemistry focused on the study of proteins—cannot be overstated. As demand f
In an ambitious move to optimize essential quality management and operational processes, Quest Nutra Pharma has partnered with Kissflow to harness the power of its Low-Code platform. This collaboration marks a significant step toward increased efficiency and accuracy in the field of nutraceutical
The biopharmaceutical industry is undergoing a transformative shift towards sustainability, driven by the dual imperatives of environmental responsibility and regulatory compliance. In a significant move to support this transition, Thermo Fisher Scientific has unveiled novel biobased versions of
US Specialty Formulations (USSF) has announced an ambitious $15 million expansion of its biopharma facility in Allentown, Pennsylvania. This initiative, highlighted in a July 31, 2024 press release, is aimed at significantly boosting the company's production capabilities and economic impact on
TPG's recent infusion of $580 million into their Life Science Innovations fund is a remarkable move, aimed at supporting advancements in breakthrough technologies and achieving clinical proof-of-concept for emerging life science companies. The substantial financial backing will target a broad
